France · Question · Question écrite
9867
Question 9867 — diseases
Introduced
—
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
—
Summary
Steatotic liver disease includes fatty liver disease and nonalcoholic steatohepatitis (NAH). Its prevalence is poorly known but it is estimated to represent the main cause of chronic liver disease in Western countries. This disease is closely associated with obesity, it is estimated that less than 15% of morbidly obese patients (BMI > 40 kg/m2) have a normal liver biopsy. Most people with Non-alcoholic fatty liver disease does not develop into a serious problem, but NASH can progress to cirrhosis. Liver damage is linked to a mechanism of insulin resistance. Diabetes, high blood pressure and hypercholesterolemia are frequently associated with fatty liver disease (between 40 and 80% of people with type 2 diabetes are affected). There is no specific drug treatment. Prevention aims to promote a healthy diet and sufficient physical activity, in accordance with the recommendations of the National Nutrition and Health Program. Various strategies are implemented for this: information and education aimed at individuals and promotion of an environment favorable to health. The deployment of the “Nutri-Score” labeling system is also an example of providing information nutritional information clear, visible and easy to understand for everyone. The treatment of SHNA is based on the search for weight loss, improvement of diet, resumption of regular physical activity and control of other cardio-metabolic risk factors. Finally, the prevention and management of steatotic liver disease are part of the priority directions of the national health strategy and on these major levers in the fight against non-communicable diseases.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/15/questions/QANR5L15QE9867
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L15QE9867